Deep Vein Thrombosis Latest News Archive

Deep Venous Thrombosis Ultrasound Protocol Recommendations

Deep Venous Thrombosis Ultrasound Protocol Recommendations

The Society of Radiologists in Ultrasound has endorsed recommendations regarding ultrasound imaging test protocols for patients with suspected deep venous thrombosis.

Atrial Fibrillation Treated With LAA Occlusion Reduces Thromboembolism Risk

Atrial Fibrillation Treated With LAA Occlusion Reduces Thromboembolism Risk

Surgical left atrial appendage occlusion is associated with a lower risk for thromboembolism-related hospital readmission in older patients with atrial fibrillation who undergo cardiac surgery.

Intermediate-Risk Pulmonary Embolism Treatment With Dabigatran

Intermediate-Risk Pulmonary Embolism Treatment With Dabigatran

Patients diagnosed with an intermediate-risk pulmonary embolism may be able to start oral anticoagulation therapy after completing 72 hours of heparin therapy during hospitalization.

FDA Approves Rivaroxaban 10 mg for Recurrent VTE

FDA Approves Rivaroxaban 10 mg for Recurrent VTE

The 10 mg dose of rivaroxaban substantially lowered the risk for recurrent venous thromboembolism.

Venous Thromboembolism Risk Linked to Lengthy Television Watching

Venous Thromboembolism Risk Linked to Lengthy Television Watching

Watching television frequently is independently associated with an increased risk for venous thromboembolism.

Venous Thromboembolism Risk in Patients Vaccinated for Influenza

Venous Thromboembolism Risk in Patients Vaccinated for Influenza

Venous thromboembolism risk does not increase with administration of the influenza vaccine in patients aged 50 years or older.

Intraocular Bleeding Risk Reduced With NOACS Compared With Warfarin

Intraocular Bleeding Risk Reduced With NOACS Compared With Warfarin

Novel oral anticoagulants lead to a one-fifth reduction in the risk of intraocular bleeding, compared with warfarin in patients with atrial fibrillation or venous thromboembolism.

Preventing Venous Thromboembolism After Hip, Knee Arthoplasty: Comparing Anticoagulant Efficacy

Preventing Venous Thromboembolism After Hip, Knee Arthoplasty: Comparing Anticoagulant Efficacy

Fondaparinux and rivaroxaban have higher efficacy of reducing venous thromboembolism after total hip or knee arthroplasty, but also an increased risk of major bleeding.

CV Events Reduced in SLE With Aspirin and Hydroxychloroquine

CV Events Reduced in SLE With Aspirin and Hydroxychloroquine

Hydroxychloroquine in combination with low-dose asprin was protective against thrombosis in SLE.

Venous Thromboembolism Reduced in Orthopedic Surgery With Rivaroxaban

Venous Thromboembolism Reduced in Orthopedic Surgery With Rivaroxaban

Patients who received 10 mg of rivaroxaban daily had decreased the rate of venous thromboembolism by 33%.

Effect of Obesity Paradox on Venous Thromboembolism Risk in Atrial Fib

Effect of Obesity Paradox on Venous Thromboembolism Risk in Atrial Fib

A meta-analysis was conducted to examine concerns surrounding direct oral anticoagulant therapy in patients with extreme high or low body weight.

Right Upper Extremity Deep Vein Thrombosis: A Case Study

Right Upper Extremity Deep Vein Thrombosis: A Case Study

A case study of a patient presented to the emergency room for right upper extremity deep vein thrombosis after rib resection and subclavian vein stent placement 15 years ago.

Venous Thromboembolism and Sepsis Risks Increase With Short-Term Oral Corticosteriods

Venous Thromboembolism and Sepsis Risks Increase With Short-Term Oral Corticosteriods

An increased risk of sepsis, venous thromboembolism and fracture was linked to short term use of oral corticosteroids.

Effect of Warfarin Dose on Patients With HIV And DVT

Effect of Warfarin Dose on Patients With HIV And DVT

Study results were contrary to investigators' hypothesis regarding warfarin dosing in patients with and without HIV.

VTE Recurrence Risk Reduced With Rivaroxaban: Q&A With EINSTEIN CHOICE Investigator

VTE Recurrence Risk Reduced With Rivaroxaban: Q&A With EINSTEIN CHOICE Investigator

Results from the EINSTEIN CHOICE trial plus an interview with investigator Philip Stephen Wells, MD, FRCP(C), MSc.

How Does Pulmonary Embolism Risk Compare After CVT vs DVT?

How Does Pulmonary Embolism Risk Compare After CVT vs DVT?

Pulmonary embolism risk after cerebral venous thromboembolism is significantly lower than after deep vein thromboembolism.

Venous Thromboembolism Risk Increased With Giant Cell Arteritis

Venous Thromboembolism Risk Increased With Giant Cell Arteritis

Patients with giant cell arteritis were more likely to experience venous thromboembolism during the first 3 months following diagnosis.

Is There Clinical Benefit to >3 Month Rivaroxaban Tx for Unprovoked VTE?

Is There Clinical Benefit to >3 Month Rivaroxaban Tx for Unprovoked VTE?

Two studies presented at CHEST 2016 revealed that rivaroxaban lowered the risk of venous thromboembolism without increasing risk of major bleeding.

Venous Thromboembolism and Migraine May Share Mechanistic Link

Venous Thromboembolism and Migraine May Share Mechanistic Link

Venous thromboembolism was only observed in patients with migraine with aura, suggesting a mechanistic link between the 2 conditions.

Sign Up for Free e-Newsletters